Fulminant liver failure: Relevance of extracorporeal hybrid liver support systems

International Journal of Artificial Organs

Volumn 19, Issue 1, 1996, Pages 7-13

  Gerlach, J ^a   Ziemer, R ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER FAILURE; SUPPORT SYSTEMS;

ACETYLCYSTEINE; AMANITIN; ANTIBIOTIC AGENT; HALOTHANE; ISONIAZID; LACTULOSE; MANNITOL; MONOAMINE OXIDASE INHIBITOR; PARACETAMOL; PROSTAGLANDIN E1; TROMETAMOL;

ARTIFICIAL LIVER; CONFERENCE PAPER; EXTRACORPOREAL CIRCULATION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION;

EID: 0029872097     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900103     Document Type: Conference Paper

References (79)

1. Jones EA, Schafer DF. Fulminant hepatic failure. In: Zakmi D, Boyer TD, eds. Hepatology: a texbook of liver desease. 2nd ed. Vol. 1 Philadelphia: W.B. Saunders, 1990; 460-92.
2. Schalm SW de Knegt RJ. Acute liver failure: definitions and pathological variants. In: Williams R, Hughes RD, eds. Acute liver failure: improved understanding and better therapy. London: Miter Press, 1991; 11-3.
3. Edmond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-8.
4. Nyberg SL, Snatford RA, Hu WS, Payne WD, Cerra FB. Hepatocyte culture systems for artificial liver support: implications for critical care medicine. Grit Care Med. 1992; 8: 1157-68.
5. Matsumura KN, Guevara GR, Huston H, et al. Hybrid bioartificial liver in hepatic failure. Preliminary clinical report. Surgery 1987; 1: 99-103.
6. Margulis MS, Erukhimov EA, Andreiman LA et al. Hemoperfusion through suspension of cryopreserved hepatocytes in the treatment of patients with acute liver failure. Research in Surgery 1990; 2: 99-102.
7. Neuziel DF, Rozga J, Moscioni AD, et al. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Surgery 1993; 113: 340-3.
8. Sussman NL, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993; 17: 43-5.
9. Rozga J, Podestra L, LePage E, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898-9.
10. Trey C, Davidson CL. The management of fulminant hepatic failure. Progress in Liver Disease 1970; 3: 282-98.
11. Bernuau J, Benhamou JP, Rueff B. Fulminant and Subfulminant liver failure: definition and causes. Semin Liver Dis 1986; 6: 97-106.
12. European association for the study of the liver. Randomized trial of steroid therapy in acute liver failure. Gut 1987; 20: 20-3.
13. O'Grady JG, Glmson AES, O'Brien CJ. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-92.
14. Ring-Larsen H, Palazzo V. Renal failure in fulminant hepatic failure and terminal cirrhosis. Gut 1985; 22: 585-91.
15. O'Grady JG, Williams RS. Acute Hepatic Failure. In: Tinker, Zapol, eds. Care of the Critically III Patient. 2 Ed. Springer 1992; 609-31.
16. Black M. Isoniacid-associated hepatitis in 114 patients. Gastroenterology 1975; 69: 389-94.
17. Zimmerman HJ. Drug-induced liver disease. Semin Liver Dis 1981; 1: 91.
18. Summary of the National Halothane Study. Possible association between halothane anesthesia and postoperative hepatic necrosis. National Academy of Science. JAMA 1963; 197: 775-83.
19. Ruprah M, Mant TG, Flanagan RJ. Acute carbon tetrachloride poisoning in 19 patients. Implications to diagnosis and treatment. Lancet 1985; 1: 1027-9.
20. Hanrahan FP, Gordon MA. Mushroom poisoning. Case reports and a review of therapy. JAMA 1984; 251: 1057-61.
21. Licht H, Seeff LB. Zimmermann HJ. Apparent potentiation of acetaminophen-toxicity by alcohol. Ann Intern Med 1980; 92: 511.
22. Kumar S. Rex DK. Failure of physicians to recognize acetaminophen hepatoxicity in chronic alcoholics. Arch Intern Med 1991; 151: 1189-91.
23. Nouel O, Henrion J, Bernuau J. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 1980; 25: 49-52.
24. Sandle GI, Layton M, Record CO, Cowan WK. Fulminant hepatic failure due to Budd-Chiari syndrome. Lancet 1980; 1: 1199.
25. Scheinberg IH, Sternlieb I. Wilson's disease. Philadelphia: W.B. Saunders, 1985.
26. Riely CA. Acute fatty liver of pregnancy. Semin Liv Dis 1987; 7: 47-54.
27. Weber FL Liver dysfunction in critical care medicine. In: Shoemaker, ed. Textbook of critical care. W.B. Saunders 1984; 581-91.
28. O'Grady JG. Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
29. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liv Dis 1986; 6: 129-37.
30. Hughes RD, Wendon J. Gimson AES. Acute Liver failure. Gut 1991; Suppl: S86-S91.
31. Bechstein WO, Rossaint R, Neuhaus P. Intensivmedizin vor und nach Lebertransplantation. In: Bertschat FL, Ibe F, Martens F, eds. Praktische Intensivmedizin, Zuckschwerdt, München 1990.
32. Williams R, Gimson AE. Intensive liver care and management of acute liver failure. Dig Dis Sci 1991; 36: 820-6.
33. Wiesner RH, Hermans PE, Rakela J, et al. Selective bowel decontamination to decrease gramnegative aerobic bacterial and Candida colonisation and prevent infection after orthotopic liver transplantation. Transplantation 1988; 45: 570-4.
34. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 1996-9.
35. Conn HO. Comparison of lactulose and neomycin in the treatment of portal-systemic encephalopathie. Gastroenterology 1977; 72: 573.
36. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminannt hepatic failure. Lancet; 1993; 341: 157-8.
37. Ede RJ, Williams R. Hepatic encephalopathie and cerebral edema. Semin Liver Dis 1986; 6: 107-18.
38. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late admission of acetylcysteine. Lancet 1990; 335: 1572-3.
39. Gimson AE, Braude S, Mellon PF, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet; 1982; 2: 681-3.
40. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-92.
41. Canaiese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut 1982; 23(7): 625-9.
42. Jones EA, Schaefer DF. Fulminant hepatic failure. In: Zakim D, Boyer TD, eds. Hepatology. Philadelphia: Saunders, 1990; 460-75.
43. Ponfick E. Experimentelle beiträge zur pathologie der leber. Virchows Arch Path Anat 1889; 118: 93.
44. Kretz R. Uber hypertrophie und regeneration des lebergewebes. Wien Klin Wschr 1894; 365.
45. Reifferscheid M, Schreiber HW, Klingelhöfer KH. Lebercirrhose, resektion und regeneration. Langenbecks Arch Klin Chir 1959; 290; 315-28.
46. Zieve L, Anderson WR, Lindblad S. Course of hepatic regeneration after 80% to 90% resection of normal rat liver. J Lab Clin Med March; 1985; 331-6.
47. Pack GT, Isalami AH, Hubbard JC, Brasfield RD. Regeneration of human liver after major hepatectomy. Surgery 1962; 52: 617-23.
48. Bengmark S. Liver regeneration. In: Pack GT, Islami AH, eds. Tumors of the liver. Berlin: Springer Verlag, 1970; 187-210.
49. Scotto J, Opolon P, Eteve J. Liver biopsy and prognosis in acute liver failure. Gut 1973; 14: 927-33.
50. Starzl TE, Groth CG, Brettschneider L. Orthotopic homotransplantation of the human liver. Ann Surg 1968; 168: 392-415.
51. Neuhaus P, Blumhard G, Sechstem WO, et al. Comparison of FK 506- and Cyclosporine- based immunosuppression in primary orthotopic liver transplantation. Transplantation 1995; 59: (in press).
52. Gordon RD, Fung J, Tzakis AG, et al. Liver transplantation at the University of Pittsburgh, 1984 to 1990. Clin Transpl 1991; 105-17.
53. Bismuth H, Samuel D, Gugenheim J. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107: 337-41.
54. Mutimer DJ, Elias E, Liver transplantation for fulminant hepatic failure. Prog Liver Dis 1992; 10: 349-67.
55. Sheil AG, McCaughan GW, Isai HI, Hawker F, Thompson JF, Dorney SF. Acute and subacute fulminant hepatic failure: the role of liver transplantation. Med J Aust 1991; 154 (11): 724-8.
56. Canpbell DA, Ham JM, McCurry JR, Lucey MR, Turcotte JG, Merion RM. Liver transplantation for fulminant hepatic failure. Am Surg 1991; 57(8): 546-9.
57. Kalayoglu M, Stratta RJ, Hoffmann RM, Belzer FO, Quadruple immunosuppressive therapy for liver transplantation. Trans Proc 1988; 20: 524-8.
58. McDiarmid SV, Klintmalm GB, Busuttil RW. FK 506 conversion for intractable rejection of the liver allograft. Transplant Int 1993; 6: 305-12.
59. Neuhaus P, Keck H, Bechstein WO, et al. Quadruple induction of immunosuppression after liver transplantation with II-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy. Transpl Proc 1993; 25(1): 587-9.
60. Starzl TE, iwatsuki SI, Esquivel C. Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985; 5: 349.
61. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Keck H. Side-to-side anastomosis of the common bile duct is the method of choice for biliary tract reconstruction after liver transplantation. Transplant Proc 1990; 22: 1571.
62. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz K-P, Keck H. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994; 219 (4): 426-34.
63. Neuhaus P, Brölsch C, Ringe B, Lauchart W, Pichlmayr R. Results of biliary reconstruction after liver transplantation. Transplant Proc 1984; 16(5): 1225-7.
64. Cofer JB, Klintmalm GB, Howard TK, et al. A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation 1990; 49(6): 1088-93.
65. Wahlberg JA, Southard JA, Belzer FO. Development of a cold storage solution for pancreas preservation. Cryobiology 1986; 23: 477.
66. Jamiesson NV, Sundberg R, Lindell S, et al. Preservation of the canine liver for 24-48 hours simple cold storage UW solution. Transplantation 1988; 46(4): 517-25.
67. Kalayoglu M, Sollinger HW, Stratta RJ, Hoffmann RM, Belzer FO. Extended preservation of the liver for clinical transplantation. Lancet 1988; 2: 617-9.
68. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. Transplantation 1992; 53: 957-78.
69. Strasberg SM, Todd KH, Molmenti EP, Hertl M. Selecting the donor liver, risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-38.
70. Kamath GS, Plevak DJ, Wiesner RH, et al. Primary nonfunction of the liver graft: when should we retransplant? Transplant Proc 1991; 23(3): 1954.
71. DeRiso BM. Postoperative care following hepatic transplantation. In: Tinker, Zapol, eds. Care of the critically ill patient, 2 Ed, Springer 1992; 621-31.
72. Knechtle S, D'Alessandro A, Reed A, et al. Liver transplantation: the university of Wisconsin experience. Transplant Proc 1991; 23(3): 1955.
73. Ringe B, Neuhaus P, Lauchart W. Experience with hepatic retransplantation. Transplant Proc 1989; 21(1): 2407-8.
74. Shaw BW, Wood RP. Improved results with retransplantation of the liver. Transplantation 1989; 21(1): 2407-8.
75. Agnes S., Avolio AW, Magalini SC, Foco M, Castagneto M. Should retransplantation still be considered for primary non-function after liver transplantation? Transpl Int 1992; S170-2.
76. 1 for primary nonfunction following liver transplantation. Transplant Proc 1989; 21 (2): 3360-1.
77. McCaughan GW, Huynh JC, Feller R, Painter D, Waugh R, Shell AGR. Fulminant hepatic failure post liver transplantation: clinical syndromes, correlations and outcomes. Transpl Int 1995; 8: 20-6.
78. Mora NP, Klinimalm GB, Cofer JB. Result after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc 1990; 22: 1509-11.
79. Powelson JA, Cosimi AB, Lewis WD, Vacanti JP, Marks WH, Jenkins RL. Hepatic retransplantation in New England - a regional experience and survival model. Transplantation 1993; 55: 802-6.